World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
44500
World Ranking
10296
National Ranking
992

Overview

Roland M. du Bois is an academic affiliated with Imperial College London in the United Kingdom. Their work is situated within the broader academic environment of this institution, contributing to its research output and academic community.

Details regarding Roland M. du Bois's specific fields of study, main topics of research, frequent co-authors, recent papers, and publication venues are not provided. Similarly, there is no available information on book publications or awards won by this researcher.

The absence of published papers and co-authors in the available data limits a detailed understanding of their research focus and collaborations. Furthermore, without specific subject areas or research topics listed, it is not possible to delineate any primary or subfields of study related to Roland M. du Bois's scholarly activities.

Despite the lack of detailed academic output, the association with Imperial College London situates the researcher within a prominent research institution known for a range of scientific and engineering disciplines. This affiliation often reflects engagement with rigorous academic standards and participation in specialized research environments.

Best Publications

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

    Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

    Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim

  • Interstitial lung disease in systemic sclerosis: a simple staging system.

    Nicole S. L. Goh;Sujal R. Desai;Srihari Veeraraghavan;David M. Hansell

  • A common MUC5B promoter polymorphism and pulmonary fibrosis

    Max A. Seibold;Anastasia L. Wise;Marcy C. Speer;Mark P. Steele

  • Induction of Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells by Transforming Growth Factor-β1 : Potential Role in Idiopathic Pulmonary Fibrosis

    Brigham C. Willis;Brigham C. Willis;Brigham C. Willis;Janice M. Liebler;Katherine Luby-Phelps;Andrew G. Nicholson

  • An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

    Keith C. Meyer;Ganesh Raghu;Robert P. Baughman;Kevin K. Brown

  • BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

    Talmadge E. King;Jürgen Behr;Kevin K. Brown;Roland M. du Bois

  • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Aryeh Fischer;Katerina M. Antoniou;Kevin K. Brown;Jacques Cadranel

  • Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

    Demosthenes Bouros;Athol U Wells;Andrew G Nicholson;Andrew G Nicholson;Thomas V Colby

  • A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

    Rachel K Hoyles;Ross W Ellis;Jessica Wellsbury;Belinda Lees

  • Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

    Tasha E. Fingerlin;Elissa Murphy;Weiming Zhang;Anna L. Peljto

  • Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

    Robert P. Baughman;Marjolein Drent;Mani Kavuru;Marc A. Judson

  • Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

    Athol U Wells;Sujal R Desai;Michael B Rubens;Nicole S L Goh

  • Fibrotic idiopathic interstitial pneumonia: The prognostic value of longitudinal functional trends

    Panagiota I. Latsi;Roland M. du Bois;Andrew G. Nicholson;Thomas V. Colby

  • Idiopathic nonspecific interstitial pneumonia: Report of an American thoracic society project

    William D. Travis;Gary Hunninghake;Talmadge E. King;David A. Lynch

  • Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

    Talmadge E King;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

    D Mukerjee;D St George;C Knight;J Davar

  • Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

Frequent Co-Authors

Athol U. Wells
Athol U. Wells Imperial College London
Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Paul W. Noble
Paul W. Noble Cedars-Sinai Medical Center
Talmadge E. King
Talmadge E. King University of California, San Francisco
Kevin K. Brown
Kevin K. Brown National Jewish Health
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Andrew G. Nicholson
Andrew G. Nicholson Royal Brompton Hospital
Steven A. Sahn
Steven A. Sahn Medical University of South Carolina
Kenneth I. Welsh
Kenneth I. Welsh Imperial College London
David M. Hansell
David M. Hansell National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As the landscape of healthcare evolves, there are more opportunities than ever for students interested in medicine—or allied fields—to explore flexible, accredited online degree options. For those aiming for leadership, an accelerated healthcare administration degree can fast-track entry into management positions, even allowing for completion in less time than traditional routes.

Registered nurses who want to become nurse practitioners now have the convenience of pursuing adn to np programs online. These bridge programs allow working professionals to enhance their credentials while balancing existing responsibilities.

Nutrition and preventive health are increasingly valued in patient care. With the availability of the best online nutrition programs, students can become nutritionists or dietitians, ready to meet growing healthcare needs in diverse settings.

For those eyeing upper-level administration, exploring the best mha programs ensures not only quality but also CAHME-accredited legitimacy—helping graduates excel in hospital or health system leadership roles.

Online degrees provide flexibility, allowing students and professionals to specialize in key areas of healthcare without pausing their careers.

Best Scientists Citing Roland M. du Bois

Trending Scientists

Recently Published Articles